Volume 13; Issue 4

Bio/Technology

Volume 13; Issue 4
1

European Patent Legislation: A Missed Opportunity

Year:
1995
File:
PDF, 126 KB
1995
2

Is virtual spectroscopy real?

Year:
1995
File:
PDF, 117 KB
1995
3

Is virtual spectroscopy real?

Year:
1995
File:
PDF, 117 KB
1995
4

A Vindication of Plant Transgenics

Year:
1995
File:
PDF, 99 KB
1995
5

Drug companies like combinatorial chemistry

Year:
1995
File:
PDF, 234 KB
1995
6

European biotech is gaining momentum

Year:
1995
File:
PDF, 252 KB
1995
7

CEOs must seek pharmaceutical partners now

Year:
1995
File:
PDF, 127 KB
1995
8

For AIDS, the FDA may be reforming itself

Year:
1995
File:
PDF, 364 KB
1995
9

Biotech needs an industry/government initiative

Year:
1995
File:
PDF, 363 KB
1995
10

Defining the scope of biotech patent claims

Year:
1995
File:
PDF, 234 KB
1995
11

New tools for biotech product development

Year:
1995
File:
PDF, 233 KB
1995
12

Biotech must consider sales incentives

Year:
1995
File:
PDF, 152 KB
1995
13

Group I Introns: New Molecular Mechanisms for mRNA Repair

Year:
1995
File:
PDF, 518 KB
1995
14

RNase P in Research and Therapy

Year:
1995
File:
PDF, 722 KB
1995
15

To Treat or Not to Treat: That Is the Question for Serum

Year:
1995
File:
PDF, 1.72 MB
1995
16

Technology and Fetal Bovine Serum Purification: A Sysiphean Task?

Year:
1995
File:
PDF, 288 KB
1995
17

Cleaning Up in the Antipodes

Year:
1995
File:
PDF, 342 KB
1995
18

Viable Alternatives to Fetal Bovine Serum

Year:
1995
File:
PDF, 316 KB
1995
19

Serum-free and Care-free? Not Quite

Year:
1995
File:
PDF, 388 KB
1995
20

The CENB Advantage

Year:
1995
File:
PDF, 210 KB
1995
28

Automation

Year:
1995
File:
PDF, 121 KB
1995
29

New Products

Year:
1995
File:
PDF, 235 KB
1995
30

Announcements

Year:
1995
File:
PDF, 103 KB
1995
31

Three M's for Successful Tech Transfer

Year:
1995
File:
PDF, 107 KB
1995